Quantbot Technologies LP Has $440000 Stake in Corcept Therapeutics Incorporated (CORT)

Mae Love
December 7, 2017

Sei Investments Company owns 3,948 shares or 0% of their USA portfolio. The firm had revenue of $42.70 million during the quarter, compared to analyst estimates of $41.64 million. The stock has a market cap of $2,077.06, a P/E ratio of 62.76 and a beta of 1.89. The stock increased 1.92% or $0.32 during the last trading session, reaching $17. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since December 4, 2016 and is uptrending.

John A. Levin decreased its stake in Morgan Stanley (MS) by 9.59% based on its latest 2017Q2 regulatory filing with the SEC. 988.30 million shares or 1.42% more from 974.49 million shares in 2017Q1 were reported. The stock increased 2.46% or $0.41 during the last trading session, reaching $17.09. About 2.77 million shares traded. It has outperformed by 108.11% the S&P500. The Cs Mckee Lp holds 273,780 shares with $15.96M value, down from 280,880 last quarter. Its up 1.35, from 1.08 in 2017Q1. 73 funds opened positions while 252 raised stakes. Cs Mckee Lp holds 273,780 shares. It was reported on Dec, 5 by Barchart.com. 56,410 were reported by Laffer Investments. Fincl Bank Of New York Mellon Corp stated it has 926,350 shares. Secor Cap Advisors Lp has 36,689 shares. Massachusetts Fincl Svcs Ma reported 0.18% of its portfolio in Morgan Stanley (NYSE:MS). Ingalls & Snyder Ltd Liability Corporation invested in 7.31 million shares. Great West Life Assurance Can accumulated 7,612 shares or 0% of the stock. Whitnell And Communications owns 17,900 shares for 0.35% of their portfolio. The biotechnology company reported $0.11 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.13 by ($0.02). Alibaba had 155 analyst reports since August 12, 2015 according to SRatingsIntel. For the past 5 years, the company's revenue has grown 0%, while the company's earnings per share has grown 16.9%. CORT's profit will be $21.69M for 21.95 P/E if the $0.19 EPS becomes a reality. After $0.11 actual EPS reported by Corcept Therapeutics Incorporated for the previous quarter, Wall Street now forecasts 72.73% EPS growth. Therefore 94% are positive. Atlantic Securities downgraded the stock to "Underweight" rating in Wednesday, February 3 report. The rating was maintained by Wedbush on Friday, July 22 with "Outperform". They set a "buy" rating and a $14.00 price objective on the stock. As per Monday, January 25, the company rating was maintained by Morgan Stanley. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. Therefore 100% are positive.

The collective rating of 2.6 for Corcept Therapeutics Incorporated (NASDAQ:CORT) also leans strongly towards the neutral end of the spectrum. The stock has "Buy" rating by Stifel Nicolaus on Friday, November 3. The company has a 50 day moving average price of $10.42 and a 200 day moving average price of $9.21. Piper Jaffray maintained Corcept Therapeutics Incorporated (NASDAQ:CORT) on Thursday, August 24 with "Buy" rating. Piper Jaffray maintained the shares of CORT in report on Friday, September 8 with "Buy" rating. The rating was initiated by Ladenburg Thalmann on Thursday, February 2 with "Buy". Geron Corporation (NASDAQ:GERN) earnings have risen with a quarterly rate of 20.4% over the last 5 years.

Atlanta anchor Sharon Reed shuts down racist woman live on-air
A former local news anchor in Cleveland gave a sharp response Tuesday to a viewer who sent her an email calling her a racial slur. Norwood is running as an independent, white Bottoms is supported by the state's Democratic Party.

Pentagon Revises Troop Numbers to 2000 in Syria; 5200 in Iraq
He said the USA -led coalition would continue to apply "continuous pressure on the terrorist networks wherever they operate". US military personnel will also continue to support local forces in Syria to stabilize liberated territory.

Almost 1000 Mohawk College students take province up on refund offer
The students dropped out in advance of yesterday's deadline to withdraw and be reimbursed without academic penalties. He says out of that 125, a total of 53 students plan on returning in January of 2018 to start their program over.

Investors sentiment increased to 2.43 in Q2 2017. State Street Corp raised its position in shares of Corcept Therapeutics by 27.6% in the first quarter. 8,749 are held by One Capital Limited Liability Corp.

Corcept Therapeutics (NASDAQ:CORT) traded down 1.57% during midday trading on Wednesday, reaching $11.31. Birchview Cap Ltd Partnership owns 95,000 shares. Schwab Charles Inv Mngmt reported 370,573 shares. State Board Of Administration Of Florida Retirement invested in 39,663 shares. The stock hit its twelve month high on 10/05/17, and twelve month low on 01/31/17. The California-based Globeflex Capital L P has invested 0.76% in the stock. Wells Fargo Mn holds 0% or 96,081 shares in its portfolio. Moreover, Tanaka Capital Management Inc has 3.77% invested in the company for 139,397 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by

Discuss This Article